{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:16:14Z","timestamp":1778220974230,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Protein-losing enteropathy (PLE) is characterized by excessive gastrointestinal protein loss, yet systematic comparative studies across etiologies remain limited. This study aimed to characterize the confirmed PLE cohort in our center, with a focused comparison between connective tissue disease-associated PLE (CTD-PLE) and lymphatic drainage disorder-associated PLE (LDD-PLE), describe follow-up observations, and explore routine clinical indicators that may assist etiologic differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 146 patients admitted to Beijing Shijitan Hospital between January 2014 and December 2024 with PLE confirmed by 99mTc-HSA scintigraphy. Patients were classified as CTD-PLE or LDD-PLE according to the final clinical diagnosis. Clinical features, laboratory findings, and available follow-up data were analyzed, and logistic regression together with receiver operating characteristic (ROC) analyses were used to explore factors associated with CTD-PLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 146 patients (median onset age 26 years; 30 CTD-PLE and 116 LDD-PLE). Edema (84.2%) and serous cavity effusions (76.7%) were the most frequent manifestations. Comparative analysis showed that CTD-PLE patients were older, predominantly female, and had more frequent thrombosis and higher D-dimer levels than LDD-PLE patients. CTD-PLE also showed distinct laboratory features, including higher total cholesterol, triglycerides, and globulin levels, whereas LDD-PLE was associated with lower lymphocyte counts and more frequent diarrhea. Multivariate analysis identified age at onset, Hb, and total cholesterol as independent predictors of CTD-PLE. The three-variable model showed good apparent discrimination in this single-center cohort (AUC\u00a0=\u00a00.890), while C3 showed the best single-variable discrimination. Among patients with available follow-up, 19\/20 CTD-PLE patients receiving glucocorticoids plus immunosuppressants achieved symptom remission with a median ALB improvement of 9.5 (3.8, 19.6) g\/L, whereas 23\/43 surgically treated LDD-PLE patients achieved symptom remission with a median ALB improvement of 2.0 (-0.5, 5.8) g\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PLE with different etiologies shows distinct clinical and laboratory patterns. Age at onset, Hb, and total cholesterol may assist preliminary etiologic differentiation, although the proposed model requires validation in independent cohorts. The observed lipid, coagulation, and correlation patterns, together with the follow-up findings, provide exploratory clues to distinct mechanisms and treatment trajectories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1760573","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:56:15Z","timestamp":1778219775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors of protein-losing enteropathy: a retrospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Wen-Tao","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Liver Research Center, Beijing Friendship Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Teng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Mei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Bin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2301594","article-title":"Protein-losing enteropathy","volume":"389","author":"Ozen","year":"2023","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.561","article-title":"Protein-losing enteropathy: case illustrations and clinical review","volume":"105","author":"Umar","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131783","article-title":"For the management of protein-losing enteropathy, gut-heart-relation in patients with Fontan circulation","volume":"400","author":"Yumita","year":"2024","journal-title":"Int J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114684","article-title":"Protein-losing enteropathy in systemic lupus erythematosus: 12 years experience from a Chinese academic center","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307087407","article-title":"Serum cholesterol in idiopathic and lupus-related protein-losing enteropathy","volume":"17","author":"Kim","year":"2008","journal-title":"Lupus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/ceg.s136803","article-title":"Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states","volume":"10","author":"Levitt","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i22.2482","article-title":"Endoscopic classification and pathological features of primary intestinal lymphangiectasia","volume":"28","author":"Meng","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei164","article-title":"Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine","volume":"45","author":"Mok","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00296-011-1827-9","article-title":"Lupus protein-losing enteropathy (LUPLE): a systematic review","volume":"31","author":"Al-Mogairen","year":"2011","journal-title":"Rheumatol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i4.746","article-title":"Experience of primary intestinal lymphangiectasia in adults: twelve case series from a tertiary referral hospital","volume":"12","author":"Na","year":"2024","journal-title":"World J Clin cases"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(01)00799-0","article-title":"Long-term followup of primary intestinal lymphangiectasia in the child. Six case reports","volume":"9","author":"Munck","year":"2002","journal-title":"Arch Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.8391","article-title":"Protein-losing gastroenteropathy related to mixed connective tissue disease: a case report of a successful outcome and literature review","volume":"56","author":"Kobayashi","year":"2017","journal-title":"Intern Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05487-5","article-title":"Sj\u00f6gren syndrome associated with protein-losing enteropathy: case-based review","volume":"40","author":"De Carvalho","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B14","article-title":"Clinical analysis of 61 cases of protein-losing enteropathy","volume":"50","author":"Zhu","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1235-2","article-title":"Clinical practice. Protein-losing enteropathy in children","volume":"169","author":"Braamskamp","year":"2010","journal-title":"Eur J Pediatr"},{"key":"B16","first-page":"45","article-title":"Gastrointestinal manifestations in systemic autoimmune diseases","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Bucur)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.871713","article-title":"The role of intestinal mucosal barrier in autoimmune disease: a potential target","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109107","article-title":"Fecal immunoglobulin A (IgA) and its subclasses in systemic lupus erythematosus patients are nuclear antigen reactive and this feature correlates with gut permeability marker levels","volume":"242","author":"Gudi","year":"2022","journal-title":"Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.30.6.906","article-title":"Factors related to outcomes in lupus-related protein-losing enteropathy","volume":"30","author":"Lim","year":"2015","journal-title":"Korean J Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919792","article-title":"Loss of gut barrier integrity in lupus","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.53","article-title":"Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE","volume":"5","author":"Ju","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.2012.06538.x","article-title":"Zonulin, regulation of tight junctions, and autoimmune diseases","volume":"1258","author":"Fasano","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci32335","article-title":"Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function","volume":"118","author":"Bode","year":"2008","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2019.10.029","article-title":"Thoracic duct-to-vein anastomosis for the management of thoracic duct outflow obstruction in newborns and infants: a case series","volume":"55","author":"Reisen","year":"2020","journal-title":"J Pediatr Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.06.066","article-title":"Reconstruction of occluded thoracic duct for treatment of chylopericardium: a novel surgical therapy","volume":"48","author":"Melduni","year":"2008","journal-title":"J Vasc Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.30613","article-title":"Characterization and treatment of thoracic duct obstruction in patients with lymphatic flow disorders","volume":"101","author":"Srinivasan","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/micr.30339","article-title":"Correction of complete thoracic duct obstruction with lymphovenous bypass: a case report","volume":"39","author":"Miller","year":"2019","journal-title":"Microsurgery"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/gut.44.1.2","article-title":"Intestinal IgA: novel views on its function in the defence of the largest mucosal surface","volume":"44","author":"Mestecky","year":"1999","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00185","article-title":"Multi-faceted functions of secretory IgA at mucosal surfaces","volume":"4","author":"Corth\u00e9sy","year":"2013","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0261-1","article-title":"Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180427","article-title":"IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria","volume":"215","author":"Nakajima","year":"2018","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.10.5367","article-title":"Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA","volume":"163","author":"Shimada","year":"1999","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.621337","article-title":"Association of serum immunoglobulins levels with specific disease phenotypes of Crohn\u2019s disease: a multicenter analysis in China","volume":"8","author":"Song","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111752","article-title":"Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease","volume":"140","author":"Zhang","year":"2021","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1760573\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:56:16Z","timestamp":1778219776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1760573\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1760573"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1760573","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1760573"}}